The findings indicated that the enhanced pathways in C0 IGFBP7+ Glioma cells included inhibiting hydrolase activity, promoting cell-substrate adhesion, aiding in wound healing, inhibiting peptidase activity, and regulating cell-substrate adhesion. This evidence concerns the gene LAP3 and central nervous system cancer.